Exploring risk factors for pediatric cancer patients admitted to the Pediatric Intensive Care Unit: insight from a multicenter observational study revealing no association with mechanical ventilation.

IF 3.1
Angela Amigoni, Sara Boscato, Maria Cristina Mondardini, Francesca Cavagnero, Luca Marchetto, Veronica Biassoni, Carolina Birolo, Gabriella Bottari, Manuela Corno, Stefania Ferrario, Giorgia Maiolo, Alessia Montaguti, Emanuele Rossetti, Immacolata Rulli, Raffaella Sagredini, Stefania Spaggiari, Luisa Vatiero, Gianluca Vigna, Matteo Martinato, Dario Gregori, Marta Pillon, Rosanna Irene Comoretto
{"title":"Exploring risk factors for pediatric cancer patients admitted to the Pediatric Intensive Care Unit: insight from a multicenter observational study revealing no association with mechanical ventilation.","authors":"Angela Amigoni, Sara Boscato, Maria Cristina Mondardini, Francesca Cavagnero, Luca Marchetto, Veronica Biassoni, Carolina Birolo, Gabriella Bottari, Manuela Corno, Stefania Ferrario, Giorgia Maiolo, Alessia Montaguti, Emanuele Rossetti, Immacolata Rulli, Raffaella Sagredini, Stefania Spaggiari, Luisa Vatiero, Gianluca Vigna, Matteo Martinato, Dario Gregori, Marta Pillon, Rosanna Irene Comoretto","doi":"10.1186/s44158-025-00275-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>To analyze risk factors for adverse outcomes in a nationally representative sample of pediatric cancer patients admitted to the PICU.</p><p><strong>Methods: </strong>An observational study composed of a 2-year retrospective phase and a 2-year prospective phase was conducted before and during PICU admission in Italian PICUs.</p><p><strong>Results: </strong>We included 518 patients, median age 7.2 years (IQR 2.5-12.6). Main diagnosis: solid tumors (51%) and acute lymphoblastic leukemia (23%). Nineteen percent underwent stem cell transplantation (HSCT). Main causes of admission were respiratory failure (33%) and neurological impairment (24%). In-PICU mortality was 15%, higher in HSCT (41%) and non-solid cancer (25%). Pre-PICU mortality risk factors included HSCT (OR 3.48, 95%CI 1.5-8.11), higher Pediatric Overall Performance Category (POPC) (OR 1.72, 95%CI 1.23-2.42), and Pediatric Index of Mortality 3 (PIM-3) score (OR 1.03, 95%CI 1.01-1.06). In-PICU mortality risk factors included multiple organ failure (MOF) (OR 4.83, 95%CI 1.66-15.71), and cardiac arrest (OR 82.16, 95%CI 14.19-1594.61). The use of MV does not appear to be associated with increased mortality. Longer PICU LOS was associated with pre-admission acute respiratory distress syndrome (p < 0.001), renal failure (p = 0.024), POPC (p = 0.007) and PIM 3 (p < 0.001), and in-PICU use of total parenteral nutrition (p = 0.036), and duration of mechanical ventilation (MV) (p < 0.001).</p><p><strong>Conclusions: </strong>HSCT, non-solid tumor, higher PIM-3, and POPC on admission, MOF, and history of cardiac arrest were associated with poorer outcome. The use of MV does not appear to be associated with increased mortality.</p><p><strong>Trial registration: </strong>ClinicalTrials.gov ID NCT04581655, October 7, 2020.</p>","PeriodicalId":73597,"journal":{"name":"Journal of Anesthesia, Analgesia and Critical Care (Online)","volume":"5 1","pages":"63"},"PeriodicalIF":3.1000,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Anesthesia, Analgesia and Critical Care (Online)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s44158-025-00275-6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: To analyze risk factors for adverse outcomes in a nationally representative sample of pediatric cancer patients admitted to the PICU.

Methods: An observational study composed of a 2-year retrospective phase and a 2-year prospective phase was conducted before and during PICU admission in Italian PICUs.

Results: We included 518 patients, median age 7.2 years (IQR 2.5-12.6). Main diagnosis: solid tumors (51%) and acute lymphoblastic leukemia (23%). Nineteen percent underwent stem cell transplantation (HSCT). Main causes of admission were respiratory failure (33%) and neurological impairment (24%). In-PICU mortality was 15%, higher in HSCT (41%) and non-solid cancer (25%). Pre-PICU mortality risk factors included HSCT (OR 3.48, 95%CI 1.5-8.11), higher Pediatric Overall Performance Category (POPC) (OR 1.72, 95%CI 1.23-2.42), and Pediatric Index of Mortality 3 (PIM-3) score (OR 1.03, 95%CI 1.01-1.06). In-PICU mortality risk factors included multiple organ failure (MOF) (OR 4.83, 95%CI 1.66-15.71), and cardiac arrest (OR 82.16, 95%CI 14.19-1594.61). The use of MV does not appear to be associated with increased mortality. Longer PICU LOS was associated with pre-admission acute respiratory distress syndrome (p < 0.001), renal failure (p = 0.024), POPC (p = 0.007) and PIM 3 (p < 0.001), and in-PICU use of total parenteral nutrition (p = 0.036), and duration of mechanical ventilation (MV) (p < 0.001).

Conclusions: HSCT, non-solid tumor, higher PIM-3, and POPC on admission, MOF, and history of cardiac arrest were associated with poorer outcome. The use of MV does not appear to be associated with increased mortality.

Trial registration: ClinicalTrials.gov ID NCT04581655, October 7, 2020.

探索儿科重症监护病房收治的儿科癌症患者的危险因素:来自一项多中心观察性研究的见解,显示与机械通气无关。
背景:分析PICU收治的具有全国代表性的儿科癌症患者不良结局的危险因素。方法:对意大利PICU患者在PICU入院前和入院期间进行为期2年的回顾性研究和为期2年的前瞻性研究。结果:纳入518例患者,中位年龄7.2岁(IQR 2.5-12.6)。主要诊断:实体瘤(51%)和急性淋巴细胞白血病(23%)。19%接受了干细胞移植(HSCT)。入院的主要原因是呼吸衰竭(33%)和神经功能障碍(24%)。picu内死亡率为15%,HSCT(41%)和非实体癌(25%)的死亡率更高。picu前的死亡危险因素包括HSCT (OR 3.48, 95%CI 1.5-8.11)、较高的儿科整体表现类别(POPC) (OR 1.72, 95%CI 1.23-2.42)和儿科死亡指数3 (PIM-3)评分(OR 1.03, 95%CI 1.01-1.06)。picu内死亡危险因素包括多器官衰竭(MOF) (OR 4.83, 95%CI 1.66-15.71)和心脏骤停(OR 82.16, 95%CI 14.19-1594.61)。MV的使用似乎与死亡率的增加无关。较长的PICU LOS与入院前急性呼吸窘迫综合征相关(p)。结论:HSCT、非实体肿瘤、入院时较高的PIM-3和POPC、MOF和心脏骤停史与较差的预后相关。MV的使用似乎与死亡率的增加无关。试验注册:ClinicalTrials.gov ID NCT04581655, 2020年10月7日。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.40
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信